GlassScriptPhysician profile
Reena J Jacob
NPI 1720015746
$3,208.30
in general payments reported to CMS, 2019-2025
19 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $279 · 2021: $429 · 2022: $688 · 2023: $377 · 2024: $853 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $428.25 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $362.01 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $358.73 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $324.78 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $315.85 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $239.78 | 2022-2025 | |
| Lilly USA, LLC | $204.43 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Exact Sciences Corporation | $174.06 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $160.68 | 2019-2022 | |
| Boston Scientific Corporation | $148.56 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.82 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $123.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $75.15 | 2022-2025 | |
| Baxter Healthcare | $67.50 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Astellas Pharma US INC | $22.06 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $22.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.29 | 2020 | |
| Esperion Therapeutics, INC. | $19.26 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.